Medicinal chemistry of non-peptidomimetic dipeptidyl peptidase IV (DPP IV) inhibitors for treatment of Type-2 diabetes mellitus: Insights on recent development
出版年份 2023 全文链接
标题
Medicinal chemistry of non-peptidomimetic dipeptidyl peptidase IV (DPP IV) inhibitors for treatment of Type-2 diabetes mellitus: Insights on recent development
作者
关键词
-
出版物
Journal of Molecular Structure
Volume 1284, Issue -, Pages 135249
出版商
Elsevier BV
发表日期
2023-03-04
DOI
10.1016/j.molstruc.2023.135249
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery
- (2022) Rameshwar S. Cheke et al. Pharmaceuticals
- Synthesis, Characterization, and Evaluation of in vitro Antidiabetic Activity of Novel Pyrrolidine Sulphonamide Derivative
- (2021) Megha Tukaram Salve et al. International Journal of Pharmaceutical Investigation
- The optimization of xanthine derivatives leading to HBK001 hydrochloride as a potent dual ligand targeting DPP-IV and GPR119
- (2020) Gang Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus
- (2020) Poonam Kalhotra et al. Biomolecules
- In silico strategies for probing novel DPP-IV inhibitors as anti-diabetic agents
- (2020) Shweta Sharma et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Anti-hyperglycaemic activity of H. rosa-sinensis leaves is partly mediated by inhibition of carbohydrate digestion and absorption, and enhancement of insulin secretion
- (2020) Prawej Ansari et al. JOURNAL OF ETHNOPHARMACOLOGY
- Design, Synthesis and Evaluation of a Series of Novel Super-long Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
- (2020) Chen Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phenanthridine Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Design, Synthesis and Biological Evaluation
- (2020) Reema Abu Khalaf et al. Current Computer-Aided Drug Design
- Inhibitory effect of chestnut (Castanea mollissima Blume) inner skin extract on the activity of α-amylase, α-glucosidase, dipeptidyl peptidase IV and in vitro digestibility of starches
- (2020) Yuyang Zhang et al. FOOD CHEMISTRY
- Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors
- (2020) Duy-Viet Vo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Structural optimization of pyrazolo[1,5-a]pyrimidine derivatives as potent and highly selective DPP-4 inhibitors
- (2020) Jian Shen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and anti-diabetic activity of novel 1, 2, 3-triazole-5-carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors
- (2020) Hossein Fasihi Dastjerdi et al. JOURNAL OF MOLECULAR STRUCTURE
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Rapid generation of novel benzoic acid–based xanthine derivatives as highly potent, selective and long acting DPP-4 inhibitors: Scaffold-hopping and prodrug study
- (2019) Qing Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors
- (2019) Katarina Tomovic et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Dual Inhibition of DPP-4 and Cholinesterase Enzymes by the Phytoconstituents of the Ethanolic Extract of Prosopis cineraria Pods: Therapeutic Implications for the Treatment of Diabetes-associated Neurological Impairments
- (2019) Heera Ram et al. Current Alzheimer Research
- Surrogating and redirection of pyrazolo[1,5- a ]pyrimidin-7(4 H )-one core, a novel class of potent and selective DPP-4 inhibitors
- (2018) Xinxian Deng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors
- (2018) Ning Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and synthesis of aminocoumarin derivatives as DPP-IV inhibitors and anticancer agents
- (2018) Rina Soni et al. BIOORGANIC CHEMISTRY
- Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors
- (2018) Reema Abu Khalaf et al. Current Computer-Aided Drug Design
- Synthesis, pharmacological evaluation and molecular docking studies of pyrimidinedione based DPP-4 inhibitors as antidiabetic agents
- (2018) Vibhu Jha et al. JOURNAL OF MOLECULAR STRUCTURE
- Rational design and synthesis of new tetralin-sulfonamide derivatives as potent anti-diabetics and DPP-4 inhibitors: 2D & 3D QSAR, in vivo radiolabeling and bio distribution studies
- (2018) Somaia S. Abd El-Karim et al. BIOORGANIC CHEMISTRY
- 1,2-Benzisoxazole-3-acetamide derivatives as dual agents for DPP-IV inhibition and anticancer activity
- (2018) Shubhendu Karandikar et al. SYNTHETIC COMMUNICATIONS
- Rapid generation of a novel DPP-4 inhibitor with long-acting properties: SAR study and PK/PD evaluation
- (2017) Hui Xie et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inter-regulation of gastric emptying and incretin hormone secretion: implications for postprandial glycemic control
- (2016) Tongzhi Wu et al. Biomarkers in Medicine
- Discovery of novel xanthine compounds targeting DPP-IV and GPR119 as anti-diabetic agents
- (2016) Gang Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of triazole based uracil derivatives as novel DPP-4 inhibitors
- (2016) Qing Li et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Design, synthesis and anti-diabetic activity of chromen-2-one derivatives
- (2016) Rina Soni et al. Arabian Journal of Chemistry
- Sulfonamide-1,3,5-triazine–thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4
- (2016) Hai-De Gao et al. RSC Advances
- Complications of Diabetes 2016
- (2016) Konstantinos Papatheodorou et al. Journal of Diabetes Research
- Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus
- (2015) Zhi-Xu He et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Teneligliptin: A Review in Type 2 Diabetes
- (2015) Lesley J. Scott CLINICAL DRUG INVESTIGATION
- Evogliptin: First Global Approval
- (2015) Paul L. McCormack DRUGS
- Saxagliptin: A Review in Type 2 Diabetes
- (2015) Sohita Dhillon DRUGS
- Alogliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
- (2015) Gillian M. Keating DRUGS
- First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus
- (2015) Kohei Kaku EXPERT OPINION ON PHARMACOTHERAPY
- The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A “Me Too” or “the Special One” Antidiabetic Class?
- (2015) Ricardo Godinho et al. Journal of Diabetes Research
- Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus
- (2014) Gillian M. Keating DRUGS
- Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors
- (2014) Bhumika D. Patel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- DPP-4 inhibitors: pharmacological differences and their clinical implications
- (2014) Antonio Ceriello et al. Expert Opinion On Drug Safety
- Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes
- (2014) Tesfaye Biftu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry
- (2013) Sung-Ho Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
- (2013) Lucienne Juillerat-Jeanneret JOURNAL OF MEDICINAL CHEMISTRY
- Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors
- (2013) Manjunath Ghate et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Recent Advances in Non-Peptidomimetic Dipeptidyl Peptidase 4 Inhibitors: Medicinal Chemistry and Preclinical Aspects
- (2012) Y. Liu et al. CURRENT MEDICINAL CHEMISTRY
- A review of the efficacy and safety of oral antidiabetic drugs
- (2012) Stephanie Aleskow Stein et al. Expert Opinion On Drug Safety
- Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes
- (2012) Rosemarie Lajara EXPERT OPINION ON PHARMACOTHERAPY
- Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening
- (2012) Cui Li et al. JOURNAL OF MOLECULAR MODELING
- Current Advances and Therapeutic Potential of Agents Targeting Dipeptidyl Peptidases-IV, -II, 8/9 and Fibroblast Activation Protein
- (2011) Shu-Jen Chen et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Management of type 2 diabetes: new and future developments in treatment
- (2011) Abd A Tahrani et al. LANCET
- Type 2 diabetes mellitus—current therapies and the emergence of surgical options
- (2011) Harold E. Lebovitz Nature Reviews Endocrinology
- Nutrient detection by incretin hormone secreting cells
- (2011) Eleftheria Diakogiannaki et al. PHYSIOLOGY & BEHAVIOR
- The Glucagonostatic and Insulinotropic Effects of Glucagon-Like Peptide 1 Contribute Equally to Its Glucose-Lowering Action
- (2010) K. J. Hare et al. DIABETES
- The dipeptidyl peptidase IV family in cancer and cell biology
- (2010) Denise M. T. Yu et al. FEBS Journal
- GIP and GLP-1, the two incretin hormones: Similarities and differences
- (2010) Yutaka Seino et al. Journal of Diabetes Investigation
- Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors
- (2009) Heiko Zettl et al. ChemMedChem
- Type 2 Diabetes and Oral Antihyperglycemic Drugs
- (2008) Mitchell Avery et al. CURRENT MEDICINAL CHEMISTRY
- (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a Novel Xanthine-Based Dipeptidyl Peptidase 4 Inhibitor, Has a Superior Potency and Longer Duration of Action Compared with Other Dipeptidyl Peptidase-4 Inhibitors
- (2008) L. Thomas et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now